Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Anticancer traits of chimeric antigen receptors (CARs)-Natural Killer (NK) cells as novel approaches for melanoma treatment

Fig. 3

NK cells cancer immunotherapy enhancement via receptors modification; NKG2A: natural killer cell group 2 member A, KIR: Killer cell immunoglobulin-like receptors, TIGIT: T cell immunoreceptor with Ig and ITIM domains, PVRIG: PVR Related Immunoglobulin Domain Containing, TIM-3: T cell immunoglobulin and mucin domain-containing protein 3, LAG-3: Lymphocyte Activating 3, DNAM-1: DNAX Accessory Molecule-1, NCR: Natural Cytotoxicity Triggering Receptor 1

Back to article page